13-VALENT PNEUMOCOCCAL VACCINE

Clinical trials for 13-VALENT PNEUMOCOCCAL VACCINE explained in plain language.

Never miss a new study

Get alerted when new 13-VALENT PNEUMOCOCCAL VACCINE trials appear

Sign up with your email to follow new studies for 13-VALENT PNEUMOCOCCAL VACCINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Malawi tests new vaccine schedule to better protect children from deadly pneumonia

⭐️ VACCINE ⭐️ Completed

This study tested whether changing the timing of pneumococcal vaccine doses works better in Malawi. Researchers compared the standard three-dose schedule (3+0) with a schedule that adds a booster at 9 months (2+1). They measured how well each schedule reduced the bacteria in chil…

Matched conditions: 13-VALENT PNEUMOCOCCAL VACCINE

Sponsor: University of Liverpool • Aim: ⭐️ VACCINE ⭐️

Last updated Mar 11, 2026 14:52 UTC

13-VALENT PNEUMOCOCCAL VACCINE

Get alerted when new 13-VALENT PNEUMOCOCCAL VACCINE trials appear

Malawi tests new vaccine schedule to better protect children from deadly pneumonia